Use of a somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic; D005260:Female; D006499:Hepatic Artery; D006801:Humans; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy* / Q000601:surgery; D008875:Middle Aged; D015282:Octreotide; D011985:Receptors, Serotonin / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014407:Tumor Cells, Cultured / Q000378:metabolism
D000970:Antineoplastic Agents; D011985:Receptors, Serotonin; D012701:Serotonin; D013004:Somatostatin; D015282:Octreotide